A Clinical Trial for Evaluation of Efficacy, Safety and Immunogenicity of GNR-127 (Recombinant ABP Antigen Protein Which Carries a Birch Pollen Allergen [BET V 1] and an Apple Allergen [MAL D 1]) in Patients With Birch Pollen Allergic Rhinitis.
Clinical trial NCT07155499 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07155499
- Sponsor
- AO GENERIUM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-07
- Primary completion
- 2025-05-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.